# Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases

> **NCT06405256** · — · UNKNOWN · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 20 (estimated)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** magnetic resonance imaging-guided adaptive radiotherapy

## Key facts

- **NCT ID:** NCT06405256
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-03
- **Primary completion:** 2025-03-18
- **Final completion:** 2025-03-18
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06405256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06405256, "Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06405256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*